Aclarion adds Lanman Spinal Neurosurgery to CLARITY study for back pain assessment

se.investing.com (Swedish)

Aclarion added Lanman Spinal Neurosurgery to its CLARITY study evaluating Nociscan for back pain. The CLARITY study is a multicenter trial assessing Nociscan's ability to identify pain-generating discs using MRI spectroscopy. Lanman Spinal Neurosurgery's inclusion expands the study to private practices. Aclarion faces financial challenges, including rapid cash depletion and unprofitability, despite potential undervaluation according to InvestingPro data.


With a significance score of 1.2, this news ranks in the top 46% of today's 32241 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Aclarion adds Lanman Spinal Neurosurgery to CLARITY study for back pain assessment | News Minimalist